| 000 | 01715 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513131158.0 | ||
| 264 | 0 | _c19971201 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0012-3692 | ||
| 024 | 7 |
_a10.1378/chest.112.5.1248 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, D J | |
| 245 | 0 | 0 |
_aEvaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. _h[electronic resource] |
| 260 |
_bChest _cNov 1997 |
||
| 300 |
_a1248-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBudesonide _xadministration & dosage |
| 650 | 0 | 4 |
_aCorticotropin-Releasing Hormone _xpharmacology |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Flow Rates |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPituitary-Adrenal System _xdrug effects |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 700 | 1 | _aLipworth, B J | |
| 773 | 0 |
_tChest _gvol. 112 _gno. 5 _gp. 1248-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.112.5.1248 _zAvailable from publisher's website |
| 999 |
_c9337418 _d9337418 |
||